Report Detail
Global Anti-Diabetic Drugs Market Professional Survey Report 2019
- RnM3800307 |
- 03 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.
Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.
Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk's diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk.
The global Anti-Diabetic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Diabetic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Diabetic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Diabetic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Diabetic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Astra Zeneca
Boehringer Ingelheim
Eli Lilly
Johnson & Johnson
Merck
Novartis
Novo Nordisk
Sanofi
Teva Pharmaceutical Industries
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Biguanides
Sulfonylureas
Meglitinides
Thiazolidinediones
Dipeptidyl Peptidase IV Inhibitors
α-Glucosidase Inhibitors
Segment by Application
Type I Diabetes
Type II Diabetes
Others
Table of Contents
Executive Summary
1 Industry Overview of Anti-Diabetic Drugs
- 1.1 Definition of Anti-Diabetic Drugs
- 1.2 Anti-Diabetic Drugs Segment by Type
- 1.2.1 Global Anti-Diabetic Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Biguanides
- 1.2.3 Sulfonylureas
- 1.2.4 Meglitinides
- 1.2.5 Thiazolidinediones
- 1.2.6 Dipeptidyl Peptidase IV Inhibitors
- 1.2.7 α-Glucosidase Inhibitors
- 1.3 Anti-Diabetic Drugs Segment by Applications
- 1.3.1 Global Anti-Diabetic Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Type I Diabetes
- 1.3.3 Type II Diabetes
- 1.3.4 Others
- 1.4 Global Anti-Diabetic Drugs Overall Market
- 1.4.1 Global Anti-Diabetic Drugs Revenue (2014-2025)
- 1.4.2 Global Anti-Diabetic Drugs Production (2014-2025)
- 1.4.3 North America Anti-Diabetic Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Anti-Diabetic Drugs Status and Prospect (2014-2025)
- 1.4.5 China Anti-Diabetic Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Anti-Diabetic Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anti-Diabetic Drugs Status and Prospect (2014-2025)
- 1.4.8 India Anti-Diabetic Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anti-Diabetic Drugs
- 2.3 Manufacturing Process Analysis of Anti-Diabetic Drugs
- 2.4 Industry Chain Structure of Anti-Diabetic Drugs
3 Development and Manufacturing Plants Analysis of Anti-Diabetic Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anti-Diabetic Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anti-Diabetic Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anti-Diabetic Drugs Production and Capacity Analysis
- 4.2 Anti-Diabetic Drugs Revenue Analysis
- 4.3 Anti-Diabetic Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Anti-Diabetic Drugs Regional Market Analysis
- 5.1 Anti-Diabetic Drugs Production by Regions
- 5.1.1 Global Anti-Diabetic Drugs Production by Regions
- 5.1.2 Global Anti-Diabetic Drugs Revenue by Regions
- 5.2 Anti-Diabetic Drugs Consumption by Regions
- 5.3 North America Anti-Diabetic Drugs Market Analysis
- 5.3.1 North America Anti-Diabetic Drugs Production
- 5.3.2 North America Anti-Diabetic Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anti-Diabetic Drugs Import and Export
- 5.4 Europe Anti-Diabetic Drugs Market Analysis
- 5.4.1 Europe Anti-Diabetic Drugs Production
- 5.4.2 Europe Anti-Diabetic Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anti-Diabetic Drugs Import and Export
- 5.5 China Anti-Diabetic Drugs Market Analysis
- 5.5.1 China Anti-Diabetic Drugs Production
- 5.5.2 China Anti-Diabetic Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anti-Diabetic Drugs Import and Export
- 5.6 Japan Anti-Diabetic Drugs Market Analysis
- 5.6.1 Japan Anti-Diabetic Drugs Production
- 5.6.2 Japan Anti-Diabetic Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anti-Diabetic Drugs Import and Export
- 5.7 Southeast Asia Anti-Diabetic Drugs Market Analysis
- 5.7.1 Southeast Asia Anti-Diabetic Drugs Production
- 5.7.2 Southeast Asia Anti-Diabetic Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anti-Diabetic Drugs Import and Export
- 5.8 India Anti-Diabetic Drugs Market Analysis
- 5.8.1 India Anti-Diabetic Drugs Production
- 5.8.2 India Anti-Diabetic Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anti-Diabetic Drugs Import and Export
6 Anti-Diabetic Drugs Segment Market Analysis (by Type)
- 6.1 Global Anti-Diabetic Drugs Production by Type
- 6.2 Global Anti-Diabetic Drugs Revenue by Type
- 6.3 Anti-Diabetic Drugs Price by Type
7 Anti-Diabetic Drugs Segment Market Analysis (by Application)
- 7.1 Global Anti-Diabetic Drugs Consumption by Application
- 7.2 Global Anti-Diabetic Drugs Consumption Market Share by Application (2014-2019)
8 Anti-Diabetic Drugs Major Manufacturers Analysis
- 8.1 Astra Zeneca
- 8.1.1 Astra Zeneca Anti-Diabetic Drugs Production Sites and Area Served
- 8.1.2 Astra Zeneca Product Introduction, Application and Specification
- 8.1.3 Astra Zeneca Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Anti-Diabetic Drugs Production Sites and Area Served
- 8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Anti-Diabetic Drugs Production Sites and Area Served
- 8.3.2 Eli Lilly Product Introduction, Application and Specification
- 8.3.3 Eli Lilly Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson Anti-Diabetic Drugs Production Sites and Area Served
- 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.4.3 Johnson & Johnson Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Merck
- 8.5.1 Merck Anti-Diabetic Drugs Production Sites and Area Served
- 8.5.2 Merck Product Introduction, Application and Specification
- 8.5.3 Merck Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Novartis
- 8.6.1 Novartis Anti-Diabetic Drugs Production Sites and Area Served
- 8.6.2 Novartis Product Introduction, Application and Specification
- 8.6.3 Novartis Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Novo Nordisk
- 8.7.1 Novo Nordisk Anti-Diabetic Drugs Production Sites and Area Served
- 8.7.2 Novo Nordisk Product Introduction, Application and Specification
- 8.7.3 Novo Nordisk Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Anti-Diabetic Drugs Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Teva Pharmaceutical Industries
- 8.9.1 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production Sites and Area Served
- 8.9.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
- 8.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Anti-Diabetic Drugs Market
- 9.1 Global Anti-Diabetic Drugs Market Trend Analysis
- 9.1.1 Global Anti-Diabetic Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anti-Diabetic Drugs Regional Market Trend
- 9.2.1 North America Anti-Diabetic Drugs Forecast 2019-2025
- 9.2.2 Europe Anti-Diabetic Drugs Forecast 2019-2025
- 9.2.3 China Anti-Diabetic Drugs Forecast 2019-2025
- 9.2.4 Japan Anti-Diabetic Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Anti-Diabetic Drugs Forecast 2019-2025
- 9.2.6 India Anti-Diabetic Drugs Forecast 2019-2025
- 9.3 Anti-Diabetic Drugs Market Trend (Product Type)
- 9.4 Anti-Diabetic Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anti-Diabetic Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Anti-Diabetic Drugs. Industry analysis & Market Report on Anti-Diabetic Drugs is a syndicated market report, published as Global Anti-Diabetic Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Anti-Diabetic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
